trending Market Intelligence /marketintelligence/en/news-insights/trending/u1D3RngouAGuvV7Kuv4-eA2 content esgSubNav
In This List

Ohr Pharmaceutical granted extension to meet Nasdaq compliance

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Ohr Pharmaceutical granted extension to meet Nasdaq compliance

Ohr Pharmaceutical Inc. was granted additional time to regain compliance with Nasdaq's minimum $1 bid price listing requirement.

The pharmaceutical company now has an additional 180 calendar days, or until April 2, 2018, to meet the listing standard.

It had received the noncompliance notice April 6 and had until Oct. 3 to regain compliance.